Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
/
Qiagen
Create a narrative
Qiagen Community
NYSE:QGEN Community
1
Narratives
written by author
0
Comments
on narratives written by author
11
Fair Values set
on narratives written by author
Community Investing Ideas
Qiagen
Popular
Undervalued
Overvalued
Qiagen
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Syndromic Diagnostics And Automation Will Shape Future Healthcare
Key Takeaways Expansion in syndromic diagnostics, automation, and bioinformatics strengthens Qiagen's market position and supports recurring revenue and margin growth through new products and partnerships. Strategic efficiency initiatives, operational focus, and innovation reinvestment enable Qiagen to scale while returning capital to shareholders and boosting long-term profitability.
View narrative
US$52.39
FV
5.1% undervalued
intrinsic discount
6.95%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
QGEN
QGEN
Qiagen
Your Fair Value
US$
Current Price
US$49.74
2.3% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
3b
2015
2018
2021
2024
2025
2027
2030
Revenue US$2.8b
Earnings US$521.1m
Advanced
Set Fair Value